Positive New Data from Phase 1/2 Trial of AT-01 Presented

AT-01 is a first-in-class pan-amyloid imaging agent capable of detecting diverse types of amyloidSensitivity in those with previously diagnosed cardiac...

Related Keywords

Washington ,United States ,Luke Heagle ,Amy Weisman ,Attralus Inc ,University Of Tennessee Research Foundation ,American College Of Cardiology ,University Of Tennessee Graduate School Medicine ,Waltere Washington Convention Center ,Cancer Theranostics Program ,Tennessee Graduate School ,American College ,Annual Scientific Session ,Poster Presentation ,Cardiac Amyloidosis ,Using Iodine Evuzamitide ,Jonathan Wall ,Distinguished Professor ,Cancer Theranostics ,Cardiac Imaging ,Convention Center ,Multimodality Imaging Moderated Poster Theater ,Fully Automated ,Amyloidophilic Radiotracer Iodine Evuzamitide ,Systemic Amyloidosis ,Multimodality Imaging ,Poster Hall ,Scientific Session ,Tennessee Research ,South San ,Attralus ,Nc ,Amyloidosis ,Iagnostic ,